Vendor, Palo Alto, CA
4J Therapeutics Inc.
UEI SZCGV7LQJKR4, CAGE 9DFF0
1 award and $63,083,814 obligated between September 18, 2024 and September 18, 2026, 100% under full and open competition, against 1.0 offers on average where reported. 9 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $63,083,814 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $63,083,814 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Hear when 4J Therapeutics Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of 4J Therapeutics Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to Office of Assistant Secretary for Preparedness and Response, by dollars.
| Advanced Technology InternationalSummerville, SC | $2,764,576,471 |
| Albert B. Sabin Vaccine Institute, Inc. (The)Washington, DC | $356,898,734 |
| Amgen USA Inc.Thousand Oaks, CA | $345,705,117 |
| Start2 Group, Inc.Cambridge, MA | $227,139,021 |
| Siga Technologies, Inc.New York, NY | $177,835,284 |
| Shionogi Inc.Florham Park, NJ | $156,109,904 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50124C00052Definitive Contract, September 18, 2024, Full and Open Competition, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | The Overall Objective of This Contract Is to Demonstrate the Versatility and Efficacy of Our Programmable Antiviral Technology Platform by ANAICS 541714, PSC AN13 | $63,083,814 |
- Places of performance
- California
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 6 across 1 awards